How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €427.95 | €501.09 |
| Amazon.com Inc. | €226.95 | €258.70 |
| Intuitive Surgical Inc | €340.85 | €507.75 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €91.38 | €91.19 |
| Western Union Co. | €6.44 | €7.01 |
| Consolidated Edison Inc. | €94.04 | €82.72 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B FutureFuel Corp. | Traumtanz | 25.73% |
| B Innovate Corp. | daimler1 | 21.24% |
| B Tenax Therapeutics Inc. | daimler1 | 19.08% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Socket Mobile Inc. | Bankster | -52.62% |
| S Socket Mobile Inc. | Lokrim | -32.77% |
| S Capricor Therapeutics Inc | Bankster | -25.80% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Space X
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Socket Mobile Inc.
WKN: A0RBSN / Name: Socket Mobile / Stock / Computers, Phones & Household Electronics / Micro Cap /
Pros
Cons
Enlivex Therapeutics Ltd.
WKN: A119KH / Name: Enlivex Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Copart Inc. | €27.30 | 6.980% |
| Sandisk Corp. | €1,430.0 | 6.770% |
| Newmont Corp. | €102.50 | 6.190% |
| Advanced Micro Devices Inc. | €444.20 | 6.000% |
| Carnival Paired Ctf | €23.45 | 5.850% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Broadcom Ltd. | €339.75 | -6.460% |
| Applied Materials Inc. | €438.35 | -5.640% |
| Workday, Inc. | €171.74 | -4.560% |
| HP Inc. | €26.03 | -4.230% |
| CrowdStrike Holdings Inc | €187.50 | -4.220% |
Courses
Key figures for stocks
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
Predictions
Astera Labs Inc.
08:39
14.08.26
Lumentum Holdings Inc
08:35
14.08.26
Ast Spacemobile Inc.
08:35
14.08.26
Top News
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
Key Points
- Interested in Progyny, Inc.? Here are five stocks we like better.
- Utilization is expected to rebound: Progyny said fertility-treatment engagement slowed more sharply than usual
Perion Network Bets on AI Platform as CTV, Retail Media Spend Accelerate
Key Points
- Interested in Perion Network Ltd? Here are five stocks we like better.
- Perion One is becoming the company’s AI-driven growth platform, with Outmax optimizing campaigns across channels
Pegasystems Touts Governed AI Workflows, Token-Free Pricing at Oppenheimer Conference
Key Points
- Interested in Pegasystems Inc.? Here are five stocks we like better.
- Pegasystems is positioning its platform for regulated, control-heavy enterprises that need predictable and
Pegasystems Highlights AI Push, Sales Reset After Soft ACV Growth
Key Points
- Interested in Pegasystems Inc.? Here are five stocks we like better.
- Pegasystems is expanding its AI capabilities through Pega Blueprint and Infinity Studio, which aim to accelerate
PacBio Cuts Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity
Key Points
- Interested in Pacific Biosciences of California, Inc.? Here are five stocks we like better.
- PacBio lowered its revenue outlook as customers transition more slowly than expected to
NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates
NRx Pharmaceuticals, Inc. (NRXP) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.98 per share a year ago
Flexible Solutions International Inc. (FSI) Reports Q2 Loss, Misses Revenue Estimates
Flexible Solutions International Inc. (FSI) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.15 per share a year ago
This Dividend Aristocrat Posted Record Quarterly Results
Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.
And when considering
Barfresh Food Group Inc. (BRFH) Reports Q2 Loss, Lags Revenue Estimates
Barfresh Food Group Inc. (BRFH) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.06 per share a year ago. These
Prairie Operating Co. (PROP) Q2 Earnings Top Estimates
Prairie Operating Co. (PROP) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.18 per share a year ago
Ouster Says Rev8 Lidar Gains Early Multimillion-Dollar Orders, Targets Broader Platform Growth
Key Points
- Interested in Ouster, Inc.? Here are five stocks we like better.
- Rev8 is gaining early traction, with Ouster reporting multimillion-dollar orders from new and existing customers
News
onsemi Boosts Utilization as AI Data Center Revenue Set to More Than Double
Key Points
- Interested in onsemi? Here are five stocks we like better.
- AI data center revenue is expected to more than double to over $500 million this year from approximately $250 million last
Universal Display Sees $20B OLED Capacity Wave Powering Long-Term Growth
Key Points
- Interested in Universal Display Corporation? Here are five stocks we like better.
- OLED manufacturers have committed more than $20 billion to new capacity, including Gen 8.6 fabs
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Key Points
- Interested in Orthofix Medical Inc.? Here are five stocks we like better.
- Orthofix restored its bone growth stimulation reimbursement, allowing it to recoup roughly $1 million lost
Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts
Key Points
- Interested in Ocugen, Inc.? Here are five stocks we like better.
- Ocugen is targeting 2027 BLA filings for its OCU400 retinitis pigmentosa and OCU410ST Stargardt disease gene
NXP Semiconductors Sees Demand Rebound as Auto, AI and Data Center Growth Accelerate
Key Points
- Interested in NXP Semiconductors N.V.? Here are five stocks we like better.
- Demand is rebounding across NXP’s markets: Book-to-bill ratios are above one, distribution inventory has
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference
Key Points
- Interested in Natera, Inc.? Here are five stocks we like better.
- Natera raised its outlook after broad-based second-quarter momentum, including record Signatera volumes, strong
Insight Enterprises Bets on AI Infrastructure, Services and Leaner Operations
Key Points
- Interested in Insight Enterprises, Inc.? Here are five stocks we like better.
- AI infrastructure and services are central to Insight’s three-year “One Insight” plan. The company
Terra Innovatum Targets 2027 Illinois Debut for SOLO Microreactor
Key Points
- Interested in Terra Innovatum Global S.R.L.? Here are five stocks we like better.
- Terra Innovatum is targeting late 2027 for the first deployment of its 1-megawatt SOLO microreactor
Nexxen International Bets on CTV, AI as Record Growth Prompts Another Outlook Raise
Key Points
- Interested in Nexxen International Ltd. Sponsored ADR? Here are five stocks we like better.
- Nexxen raised its full-year outlook for the third time, now expecting 12% net revenue
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobieren
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.